HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

respiratory syncytial virus immune globulin intravenous

indicated for the prevention of serious RSV (respiratory syncytial virus) infection in infants
Also Known As:
RSV-IGIV; Respigam
Networked: 20 relevant articles (3 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: 2 articles (12/2003 - 12/2003)
2. Kiener, P A: 1 article (01/2008)
3. Losonsky, G A: 1 article (01/2008)
4. Pfarr, D S: 1 article (01/2008)
5. Wu, H: 1 article (01/2008)
6. Long, Sarah S: 1 article (12/2003)
7. Meissner, H Cody: 1 article (12/2003)
8. Boulad, F: 1 article (02/2002)
9. Casson, A: 1 article (02/2002)
10. Kiehn, T E: 1 article (02/2002)

Related Diseases

1. Respiratory Syncytial Virus Infections
2. Bronchopulmonary Dysplasia
3. Virus Diseases (Viral Diseases)
4. Congenital Heart Defects (Congenital Heart Defect)
5. Respiratory Tract Infections (Respiratory Tract Infection)

Related Drugs and Biologics

1. Palivizumab
2. Intravenous Immunoglobulins (IVIG)
3. Monoclonal Antibodies
4. Neutralizing Antibodies
5. Cyclophosphamide (Cytoxan)
6. respiratory syncytial virus immune globulin intravenous
7. Ribavirin (Virazole)
8. Immunoglobulins (Immunoglobulin)
9. Globulins
10. Humanized Monoclonal Antibodies

Related Therapies and Procedures

1. Therapeutics
2. Length of Stay